startup
France’s Bionyra Pharma launches with €143 million Series A to advance inflammatory disease biologics
Source:
eu-startups.com 1 min read
Share
You are reading a summary. The full content is hosted on eu-startups.com.
Bionyra Pharma, a Paris and Boston-based clinical-stage biopharma company developing next-generation biologics for immune-mediated inflammatory diseases, today announced the company’s launch and its €143 million ($165 million) oversubscribed Series A financing The round is co-led by Jeito Capital and Sofinnova Partners. Arkin Bio, Sanofi Ventures, Sixty Degree Capital, Vives Partners and Apollo Health Ventures also […] The post France’s Bionyra Pharma launches with €143 million Series A to advance inflammatory disease biologics appeared first on EU-Startups.
Read the full article on the original website
External link to eu-startups.com
Related Articles
startup
Sources: Uber halts plans to launch food delivery in five of the seven European countries it had targeted for expansion as it pursues a Delivery Hero takeover (Kieran Smith/Financial Times)
1 min read •
startup
India issues a notice to Telegram, asking it to curb the spread of pirated films and other copyrighted content, and seeks an action-taken report within 15 days (Sejal Sharma/Hindustan Times)
1 min read •
startup
Trump's God, guns and anticommunist Fourth of July
2 min read •